Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 57 results.
User Information
Export Records
  1. 1.   Transcriptionally-active "defective" HIV-1 proviruses and their association with immunological non-response to antiretroviral therapy
  2. Scrimieri, Francesca; Bastian, Estella; Smith, Mindy; Rehm, Catherine A; Morse, Caryn; Kuruppu, Janaki; McLaughlin, Mary; Chang,Weizhong; Sereti, Irini; Kovacs, Joseph A; Lane, H Clifford; Imamichi, Hiromi
  3. The Journal of Infectious Diseases. 2024, Jan 16;
  1. 2.   Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
  2. Nalawade, Saisha A; Shafer, Paul; Bajgain,Pradip; McKenna, Mary K; Ali, Arushana; Kelly, Lauren; Joubert, Jarrett; Gottschalk, Stephen; Watanabe, Norihiro; Leen, Ann; Parihar, Robin; Vera Valdes, Juan Fernando; Hoyos, Valentina
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 3.   Human Plasma-like Medium Improves T Lymphocyte Activation
  2. Leney-Greene, Michael A; Boddapati,Arun Kumar; Su, Helen C; Cantor, Jason R; Lenardo, Michael J
  3. iScience. 2020, JAN 24; 23(1): 100759.
  1. 4.   The frequency of alpha(4)beta(7)(high) memory CD4(+) T cells correlates with susceptibility to rectal simian immunodeficiency virus infection
  2. Martinelli, E.; Veglia, F.; Goode, D.; Guerra-Perez, N.; Aravantinou, M.; Arthos, J.; Piatak, M., Jr.; Lifson, J. D.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Journal of acquired immune deficiency syndromes (1999). 2013, 1-Dec; 64(4): 325-31.
  1. 5.   Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand
  2. Jain, A.; Kovacs, J. A.; Nelson, D. L.; Migueles, S. A.; Pittaluga, S.; Fanslow, W.; Fan, X. Y.; Wong, D. W.; Massey, J.; Hornung, R.; Brown, M. R.; Spinner, J. J.; Liu, S. Y.; Davey, V.; Hill, H. A.; Ochs, H.; Fleisher, T. A.
  3. Blood. 2011, Oct; 118(14): 3811-3817.
  1. 7.   Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission
  2. Van Prooyen, N.; Gold, H.; Andresen, V.; Schwartz, O.; Jones, K.; Ruscetti, F.; Lockett, S.; Gudla, P.; Venzon, D.; Franchini, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Nov; 107(48): 20738-20743.
  1. 8.   Macrophages and Cell-Cell Spread of HIV-1
  2. Waki, K.; Freed, E. O.
  3. Viruses-Basel. 2010, Aug; 2(8): 1603-1620.
  1. 9.   3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells
  2. Felts, R. L.; Narayan, K.; Estes, J. D.; Shi, D.; Trubey, C. M.; Fu, J.; Hartnell, L. M.; Ruthel, G. T.; Schneider, D. K.; Nagashima, K.; Bess, J. W.; Bavari, S.; Lowekamp, B. C.; Bliss, D.; Lifson, J. D.; Subramaniam, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Jul; 107(30): 13336-13341.
  1. 10.   Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray
  2. Oyelaran, O.; Gildersleeve, J. C.
  3. Proteomics Clinical Applications. 2010, Mar; 4(3): 285-294.
  1. 11.   Minireview: Nanoparticles and the Immune System
  2. Zolnik, B. S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M. A.
  3. Endocrinology. 2010, Feb; 151(2): 458-465.
  1. 12.   TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Current directions in autoimmunity. 2010 11: 119-34.
  1. 13.   Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine
  2. Klinman, D. M.; Yamamoto, M.; Tross, D.; Tomaru, K.
  3. Expert Opinion on Biological Therapy. 2009, Dec; 9(12): 1477-86.
  1. 14.   Alarmins and antimicrobial immunity
  2. Yang, D.; Oppenheim, J. J.
  3. Medical Mycology. 2009 47(Suppl 1): S146-53.
  1. 15.   Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda
  2. Reynolds, S. J.; Nakigozi, G.; Newell, K.; Ndyanabo, A.; Galiwongo, R.; Roaz, I.; Quinn, T. C.; Gray, R.; Wawer, M.; Serwadda, D.
  3. Aids. 2009 23(6): 697-700.
  1. 16.   Development of regulatory T cells requires IL-7R alpha stimulation by IL-7 or TSLP
  2. Mazzucchelli, R.; Hixon, J. A.; Spolski, R.; Chen, X.; Li, W. Q.; Hall, V. L.; Willette-Brown, J.; Hurwitz, A. A.; Leonard, W. J.; Durum, S. K.
  3. Blood. 2008, Oct 15; 112(8): 3283-3292.
  1. 17.   The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
  2. Wuest, T. Y.; Willette-Brown, J.; Durum, S. K.; Hurwitz, A. A.
  3. Journal of Leukocyte Biology. 2008 84(4): 973-980.
  1. 18.   Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin
  2. Ilani, T.; Khanna, C.; Zhou, M.; Veenstra, T. D.; Bretscher, A.
  3. Journal of Cell Biology. 2007, Nov; 179(4): 733-746.
  1. 19.   Deletion of CD4 and CD8 coreceptors permits generation of alpha beta T cells that recognize antigens independently of the MHC
  2. Van Laethem, F.; Sarafova, S. D.; Park, J. H.; Tai, X.; Pobezinsky, L.; Guinter, T. I.; Adoro, S.; Adams, A.; Sharrow, S. O.; Feigenbaum, L.; Singer, A.
  3. Immunity. 2007, Nov; 27(5): 735-750.
  1. 20.   A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum
  2. Stahl-Hennig, C.; Eisenblatter, M.; Franz, M.; Stoiber, H.; Tenner-Racz, K.; Suh, Y. S.; Jasny, E.; Falkensammer, B.; Ugucchioni, M.; Georgsson, G.; Baroni, C.; Dierich, M. P.; Lifson, J. D.; Steinman, R. M.; Uberla, K.; Racz, P.; Ignatius, R.
  3. Frontiers in Bioscience. 2007, Jan; 12: 2107-2123.
  1. 21.   Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro
  2. Stone, G. W.; Barzee, S.; Snarsky, V.; Spina, C. A.; Lifson, J. D.; Pillai, V. K. B.; Amara, R. R.; Villinger, F.; Kornbluth, R. S.
  3. Clinical and Vaccine Immunology. 2006, Nov; 13(11): 1223-1230.
  1. 22.   Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia-Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A.
  3. Virology. 2006, Sep; 353(2): 451-462.
  1. 23.   Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE
  2. Chen, X.; Oppenheim, J. J.; Winkler-Pickett, R. T.; Ortaldo, J. R.; Howard, O. M. Z.
  3. European Journal of Immunology. 2006, Aug; 36(8): 2139-2149.
  1. 24.   Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection
  2. Estes, J. D.; Li, Q. S.; Reynolds, M. R.; Wietgrefe, S.; Duan, L. J.; Schacker, T.; Picker, L. J.; Watkins, D. I.; Lifson, J. D.; Reilly, C.; Carlis, J.; Haase, A. T.
  3. Journal of Infectious Diseases. 2006, Mar; 193(5): 703-712.
  1. 25.   Membrane TNF confers protection to acute mycobacterial infection
  2. Fremond, C.; Allie, N.; Dambuza, I.; Grivennikov, S. I.; Yeremeev, V.; Quesniaux, V. F. J.; Jacobs, M.; Ryffel, B.
  3. Respiratory Research. 2005, NOV 14; 6(Art. No 136):
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel